• Genzyme ready to reveal results of secret gene therapy study. This one caught us off-guard! [Xconomy]

• Galderma licenses NovaBay Pharmaceuticals’ Aganocide compounds for dermatology indications; $50M deal. [BizJournals]

• Allos Therapeutics submits Pralatrexate NDA. [The Street]

• Alnara Pharmaceuticals Licenses Worldwide Rights to Liprotamase from Cystic Fibrosis Foundation; $50M price tag to get to finish line. [EarthTimes]

• Bristol-Myers executives get paid to NOT RIDE around in private jets. Hmmm…that would be a tough one for me. [BNET Pharma]

• Fablyn approved in EU, Pfizer seeks partner? [Bloomberg]

And that’s it…slow today

Image from unh

Related Posts